NASDAQ:BNTX
BioNTech (BNTX)
Financials 
Technical Analysis ;fill-opacity:1;'/%3e%3cpath%20d='M31%2018.6001V30H8V18.6001L14.1334%2022.4334L19.4999%2014L24.8669%2022.4334L31%2018.6001Z'%20fill='%23EE5432'%20style='fill:%23EE5432;fill:color(display-p3%200.9340%200.3310%200.1956);fill-opacity:1;'/%3e%3c/svg%3e){kind=small}
Premium content
Premium contentPremium contentThis $24 billion German based pharma company has received approvals to continue advancement into a new uterine cancer treatment. It trades at 8x trailing earnings, 1.1x book and supports a 23% ROE. Cash reserves are growing, while stock is bought back. We recommend placing a stop-loss at $78, looking to achieve $137 -- upside potential of 31%. Yield 0%
(Analysts’ price target is $137.07)Premium contentPremium contentThe $28 billion biotech just received FDA approval of their updated COVID vaccine. It trades at 6x earnings, 1.3x book and supports a 23% ROE. We like that cash reserves are growing, while shares are bought back and debt is retired. We recommend placing a stop-loss at $100, looking to achieve $161 -- upside potential of 40%. Yield 0%
(Analysts’ price target is $161.34)
Provides the key insight into mRNA that underlies the Covid vaccine. The mRNA technology can be developed into therapies that are targeted and safe. They are working on a flu vaccine as well as a cancer vaccine. Their pipeline is vast and the coronavirus vaccine is giving a huge cash hoard to pay for R&D. (Analysts’ price target is $185.00)
JoAnne Feeney- «
- ‹
- 1
- ›
- »
BioNTech (BNTX) Frequently Asked Questions
What is BioNTech stock symbol?
BioNTech is a American stock, trading under the symbol BNTX (previously BNTX-Q on Stockchase) on the NASDAQ (BNTX). It is usually referred to as NASDAQ:BNTX or BNTX
Is BioNTech a buy or a sell?
In the last year, there was no coverage of BioNTech published on Stockchase.
Is BioNTech a good investment or a top pick?
BioNTech was recommended as a Top Pick by JoAnne Feeney on 2021-05-14. Read the latest stock experts ratings for BioNTech.
Why is BioNTech stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.
Is BioNTech worth watching?
0 stock analysts on Stockchase covered BioNTech in the last year. It is a trending stock that is worth watching.
What is BioNTech stock price?
On 2026-06-01, BioNTech (BNTX) stock closed at a price of $91.70.
Our PAST TOP PICK with BNTX has triggered its stop at $95. To remain disciplined, we recommend covering the position at this time.